Biologix at the 34th Annual Conference of the Saudi Heart Association 2023
Biologix has participated in the 34th Annual Conference of the Saudi Heart Association (SHA) held from October 12 to 14, 2023 as a golden sponsor. This participation aimed to foster knowledge exchange and education among consultant cardiologists, emphasizing our commitment to advancing healthcare in the MENA region.
A significant highlight of Biologix's participation was the launch of a new indication, CVRR. This groundbreaking development was shared with the main target audience - cardiologists specializing in secondary prevention for established CVD patients.
Moreover, Biologix remains dedicated to driving innovation and education in the healthcare sector, transforming patient care.